The Use of Anthelmintics in the Treatmenlt of Ascariasis
Abstract
Ninety-seven children with Ascariasis were treated at randomly with Piperazine, Tetramisole, and Pyrantel pamoate in a single dose with cure rates of 59%, 62%, and 88%, respectively. In the children who were not cured, a reduction in egg count of nearly 80% was found in all three treatment groups. The results of this study showed that Pyrantel pamoate is the most effective of the three drugs.
References
2. CHANCO, P.P.; CABE, E. and VIDAD, Ma., J.J. Y. : The efficacy of Pyrantel pamoate iJn the treatment
of Ascariasis (a comparative study with Piperazine and Tetramisole). Proceeding on the lOth Southeast
Asian Regional Seminar on Tropical Medicine, Bangkok, October 26-30, 1971.
3. HSIEH, M.G. and CHEN, E.R. : Evaluation of Anthelmilntic activity of Pyrantel pamoate (Combantrin) against Ascaris and Hookworm. Chin. J. Microbiol. 3 : 126 (1970).
4. KOSIN, E. : Some aspects on the treatment of Ascariasis and Hookworm infection in North Sumatra. Abstract. Seminar on Public Health Research. Jakarta, July 31-August 3, 1973.
5. RIM, H.J. rund LIM, J.K. : Treatment of Enterobiasis and Ascariasis with Combantrin. Proceeding on the 10th Southeast Asian Regional Seminar on Tropical Medicine, Bangkok, October 26-30, 1971.
6. SEFTEL, H.C. and HEINZ, H.J.; Comparison on Piperazine and Tetramisole in treatment of Ascariasis. Br.
Med. J . 4 : 93 (1968).
7. W.H.O. Expert Committee : Control of Ascariasis. W.H.O. Tech. Rep. Ser. 879 (1967).
Copyright (c) 2019 Djauhar Ismail, Utomo Utomo, Sugeng Yuwono, Noerhayati S.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Published 2019-09-18